HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages
Folia Pharmacologica Japonica · 01.11.2026 · 161 (6) · 454-456
DOI: 10.1254/fpj.26070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Folia Pharmacologica Japonica, erschienen am 01.11.2026. Verfasst von Shuhei Tomita und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Graduate School of Medicine, Osaka Metropolitan University. Hauptthemen laut MEDLINE: Neoplasms, Prolyl-Hydroxylase Inhibitors, Tumor-Associated Macrophages, Hypoxia-Inducible Factor 1. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Graduate School of Medicine, Osaka Metropolitan University.
Zitieren
APA
Tomita, S., & Matsunaga, S. (2026). HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages. Folia Pharmacologica Japonica, 161(6), 454-456. https://doi.org/10.1254/fpj.26070
Vancouver
Tomita S, Matsunaga S. HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages. Folia Pharmacologica Japonica. 2026;161(6):454-456. doi:10.1254/fpj.26070
BibTeX
@article{Tomita2026,
author = {Tomita, Shuhei and Matsunaga, Shinji},
title = {HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages},
journal = {Folia Pharmacologica Japonica},
year = {2026},
volume = {161},
number = {6},
pages = {454--456},
doi = {10.1254/fpj.26070}
}
EUVIMED